Mitochondrial Dysfunction in Type 2 Diabetes Mellitus: Imeglimin as a Novel Therapeutic Approach. AJD [Internet]. 2025 Nov. 14 [cited 2025 Dec. 6];25(2):6-20. Available from: https://ojs.ijcp.in/index.php/AJD/article/view/1286